CA2128078A1 - Nutritional product for trauma and surgery patients - Google Patents

Nutritional product for trauma and surgery patients

Info

Publication number
CA2128078A1
CA2128078A1 CA002128078A CA2128078A CA2128078A1 CA 2128078 A1 CA2128078 A1 CA 2128078A1 CA 002128078 A CA002128078 A CA 002128078A CA 2128078 A CA2128078 A CA 2128078A CA 2128078 A1 CA2128078 A1 CA 2128078A1
Authority
CA
Canada
Prior art keywords
trauma
nutritional product
surgery patients
product
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002128078A
Other languages
French (fr)
Other versions
CA2128078C (en
Inventor
Mary F. Henningfield
John W. Mcewan
Robert H. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Mary F. Henningfield
John W. Mcewan
Robert H. Miller
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mary F. Henningfield, John W. Mcewan, Robert H. Miller, Abbott Laboratories filed Critical Mary F. Henningfield
Publication of CA2128078A1 publication Critical patent/CA2128078A1/en
Application granted granted Critical
Publication of CA2128078C publication Critical patent/CA2128078C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/80—Geriatric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/81—Energy rations, e.g. emergency rations, survival rations

Abstract

A liquid nutritional product for trauma and surgery patients has a caloric density of about 1.2 to 1.5 Kcal/mL and a calo-rie to nitrogen ratio of about 112:1 to 145:1. A portion of the protein system comprises partially digested protein, and supplemen-tal L-arginine provides about 1-3 % of the total calories in the product. The lipid system has a ratio of linoleic acid to alpha lino-leic acid in the range of about 3.5:1 to about 5.5:1.
CA002128078A 1992-02-26 1993-02-08 Nutritional product for trauma and surgery patients Expired - Lifetime CA2128078C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US840,972 1992-02-26
US07/840,972 US5221668A (en) 1992-02-26 1992-02-26 Nutritional product for trauma and surgery patients
PCT/US1993/001100 WO1993016595A1 (en) 1992-02-26 1993-02-08 Nutritional product for trauma and surgery patients

Publications (2)

Publication Number Publication Date
CA2128078A1 true CA2128078A1 (en) 1993-09-02
CA2128078C CA2128078C (en) 2002-03-19

Family

ID=25283701

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002128078A Expired - Lifetime CA2128078C (en) 1992-02-26 1993-02-08 Nutritional product for trauma and surgery patients

Country Status (12)

Country Link
US (1) US5221668A (en)
EP (1) EP0630181B1 (en)
JP (1) JP2644086B2 (en)
AU (1) AU3614393A (en)
CA (1) CA2128078C (en)
DE (1) DE69325091T2 (en)
DK (1) DK0630181T3 (en)
GR (1) GR3030642T3 (en)
HK (1) HK1011597A1 (en)
MX (1) MX9300999A (en)
NZ (1) NZ249392A (en)
WO (1) WO1993016595A1 (en)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126679C1 (en) * 1990-10-01 1999-02-27 Бригхэм энд Уименз Хоспитал Method of inhibition and prophylaxis of vascular symptoms rising by beta-carotene and vitamin e, a pharmaceutical composition consisting of beta-carotene and vitamin e, a pharmaceutical composition consisting of beta-carotene and aspirin
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5714161A (en) * 1993-04-22 1998-02-03 Colgate Palmolive Company Syringeable enteral diet for animals in a hypermetabolic state caused by the stress of medical and surgical illness
US5424299A (en) * 1993-04-23 1995-06-13 Monte; Woodrow C. Composition and method for rejuvenating enteral feeding tubes
US5700782A (en) * 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
US5480872A (en) * 1993-05-28 1996-01-02 Abbott Laboratories Method of providing enternal nutritional support to persons infected with human immunodeficiency virus
US5514655A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Enteral nutritional with protein system containing soy protein hydrolysate and intact protein
US5514656A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy
US5547927A (en) * 1993-05-28 1996-08-20 Abbott Laboratories Enteral nutritional product for patients undergoing radiation therapy and/or chemotherapy
US5403826A (en) * 1993-05-28 1995-04-04 Abbott Laboratories Nutritional product for persons infected with human immunodeficiency virus
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
US5723446A (en) * 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5656588A (en) * 1994-07-19 1997-08-12 Wake Forest University Wound healing formula
US5550113A (en) * 1994-07-20 1996-08-27 Mann; Morris A. Blood sugar regulating composition and methods relating thereto
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US6190704B1 (en) * 1994-09-23 2001-02-20 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Regulation of wound healing by nitric oxide
US5589468A (en) * 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5698222A (en) * 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
CA2222176A1 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Compliance support package for increasing health management system compliance
US5639471A (en) * 1995-06-06 1997-06-17 Campbell Soup Company Method for determining diet program effectiveness
CA2222278C (en) * 1995-06-06 2008-05-13 Campbell Soup Company Mineral supplements for dietetic food
US6039989A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Prepackaged therapeutic meal for treatment of diet-responsive conditions
EP0833570A1 (en) * 1995-06-06 1998-04-08 Campbell Soup Company Therapeutic system for dietary health management
DE19528461A1 (en) * 1995-08-03 1997-02-06 Braun Melsungen Ag Preparation for nutrition
US5635199A (en) * 1995-10-27 1997-06-03 Nestec Ltd. Support of pediatric patients
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
ES2132021B1 (en) * 1997-05-28 2000-02-16 Riera Simon Schwartz AMINO ACID FORMULAS FOR PERSONS OF THE OLDER AGE AND PROCEDURE FOR THE CALCULATION OF THE SAME.
US6281244B1 (en) * 1997-06-05 2001-08-28 Novartis Nutrition Ag Therapeutic use for glycine
ATE329500T1 (en) * 1997-09-16 2006-07-15 Nestle Sa USE OF AN ORGAN-SPECIFIC FOOD
US6200950B1 (en) 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
WO1999051252A1 (en) * 1998-04-03 1999-10-14 The Daily Wellness Company Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
US20050196470A9 (en) * 1998-04-03 2005-09-08 Wuh Hank C Method and composition for enhancing sexual desire
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
EP0960572A1 (en) 1998-05-12 1999-12-01 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
US6288116B1 (en) 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US7413759B2 (en) * 1998-05-21 2008-08-19 Beech-Nut Nutrition Corporation Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
US7141266B2 (en) * 1998-05-21 2006-11-28 Beech-Nut Nutrition Corporation Baby-food compositions enhancing visual acuity and methods therefor
US6579551B1 (en) 1998-05-21 2003-06-17 Beech-Nut Nutrition Corporation Baby-food compositions containing egg yolk and methods therefor
US6149964A (en) * 1998-05-21 2000-11-21 Beech-Nut Nutrition Corporation Egg yolk-containing baby food compositions and methods therefor
US6245379B1 (en) 1998-09-30 2001-06-12 The Iams Company Method of administering a milk substitute to critical care animals
DE50010583D1 (en) * 1999-01-29 2005-07-28 Sportmedizin Team Vertriebs Gm Composition for enhancing the performance of sports activities, their production and use as dietetic food
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
WO2001011990A1 (en) * 1999-04-29 2001-02-22 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
US6605115B1 (en) * 1999-06-05 2003-08-12 Board Of Trustees Of The Leland Stanford Junior University Method and composition for inhibiting cardiovascular cell proliferation
MXPA01003054A (en) * 1999-07-27 2003-07-14 Kemin Ind Inc Composition for extending post meal satiety.
US6838431B2 (en) * 1999-07-27 2005-01-04 Pacific Health Laboratories, Inc. Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
US6214373B1 (en) * 1999-10-07 2001-04-10 Snowden-Sutton Associates, Inc. Nutritional composition for treating inflammatory bowel diseases
CA2388754C (en) * 1999-10-13 2010-07-13 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
SE523432C2 (en) * 2000-01-12 2004-04-20 Mjoelkkannan Foervaltning Ab C Nutritional Drink
US6989164B2 (en) * 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US6497885B2 (en) * 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US6989171B2 (en) * 2001-04-02 2006-01-24 Pacifichealth Laboratories, Inc. Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US7740893B2 (en) * 2001-04-02 2010-06-22 Mott's Llp Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
KR20010070584A (en) * 2001-05-25 2001-07-27 한승관 The manufacture and utilization methods of a new functional material utilizing nitric oxide and linoleic acid
US6605310B2 (en) 2001-06-06 2003-08-12 Nestec S.A. Calorically dense liquid oral supplement
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
EP1532108B1 (en) * 2002-07-29 2016-06-29 Cardax Pharma, Inc. Astaxanthin esters for the inhibition and amelioration of disease
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US8100879B2 (en) 2002-11-18 2012-01-24 Nestec S.A. Connector device for enteral administration set
RU2356247C2 (en) * 2003-03-18 2009-05-27 Новартис Аг Combinations and compositions containing fatty acids and amino acids, their application for prevention and delay of progressing or treatment of diabetes and diabetes associated diseases and conditions, method of weight reduction in mammal, kit
EP1475434A1 (en) * 2003-05-09 2004-11-10 Oncoscience AG Method for storing tumor cells
AU2005218539A1 (en) * 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
EP1750723A1 (en) * 2004-04-14 2007-02-14 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20050271726A1 (en) * 2004-06-02 2005-12-08 Albert Crum Immune enhancing compositions and methods of use thereof
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US8883814B2 (en) 2006-06-05 2014-11-11 Keyview Labs, Inc. Compositions and methods for enhancing brain function
US10105405B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
US20070281961A1 (en) * 2006-06-05 2007-12-06 Brite Age Modified Compositions And Methods For Enhancing Brain Function
US8071610B2 (en) * 2006-06-05 2011-12-06 Josh Reynolds Compositions and methods for enhancing brain function
US9308232B2 (en) 2006-06-05 2016-04-12 Keyview Labs, Inc. Compositions and methods for enhancing brain function
US10105406B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
US20080050486A1 (en) * 2006-08-23 2008-02-28 Shengying Zhou Method For Suppression of Fishy Aromas In Food Products By Proteins
US20080145506A1 (en) * 2006-12-18 2008-06-19 Bodybio, Inc. Food compositions and products containing balanced ratio of essential fatty acids
US20090258833A1 (en) * 2008-04-10 2009-10-15 Edward Walker Fortified liquid protein compositions and methods of making same
WO2010081862A2 (en) * 2009-01-14 2010-07-22 Katholieke Universiteit Leuven, K.U. Leuven R&D Methods and preparations for protecting critically ill patients
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
WO2014099795A1 (en) 2012-12-18 2014-06-26 Abbott Laboratories Low viscosity, high caloric density oral nutritional composition and related methods
WO2014163975A1 (en) * 2013-03-12 2014-10-09 Abbott Laboratories Composition comprising a multifunctional viscosity modifying agent
US10568337B1 (en) * 2014-04-30 2020-02-25 Jayson Calton Method and composition for providing liquid coconut oil
EP3411016A1 (en) * 2016-02-03 2018-12-12 Fresenius Kabi Deutschland GmbH High caloric, high protein nutritional formula
ES2737950T3 (en) * 2016-09-23 2020-01-17 Fresenius Kabi Deutschland Gmbh Liquid nutritional compositions rich in calories treated by UHT
BR112019009757B1 (en) * 2016-11-16 2022-12-20 Fresenius Kabi Deutschland Gmbh PUFA, VITAMIN E, VITAMIN D AND THE AMINO ACIDS BOUND TO THE PROTEINS GLYCINE, ARGININE AND TRYPTOPHAN, THEIR USE IN THE MANUFACTURE OF A NUTRITIONAL COMPOSITION TO TREAT SARCOPENIA AND/OR WEAKNESS AND NUTRITIONAL COMPOSITION
US11147835B1 (en) 2020-08-20 2021-10-19 Frank Kelly Reilly, III Nutritional supplement

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042688A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of providing high-protein nutrition by the oral administration of a predigested protein composition
US4438144A (en) * 1980-07-31 1984-03-20 Blackburn George L Amino acid preparation and therapy for treatment of stress and injury
FR2556593B1 (en) * 1983-12-20 1987-01-02 Synthelabo NUTRITIONAL COMPOSITION CONTAINING ALPHA-CETOISOCAPROIC ACID, LEUCIN AND ESSENTIAL AND NON-ESSENTIAL AMINO ACIDS
JPS61192245A (en) * 1985-02-21 1986-08-26 Snow Brand Milk Prod Co Ltd Powdery milk containing arginin
US4850704A (en) * 1986-08-28 1989-07-25 Ladish Co. Two stage blender
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
EP0312612B1 (en) * 1987-05-01 1993-03-24 Otsuka Pharmaceutical Co., Ltd. Nutritive emulsion
EP0362724A3 (en) * 1988-10-07 1991-10-09 BASF Aktiengesellschaft Thermoplastic moulding compositions
ATE192037T1 (en) * 1989-12-29 2000-05-15 Braun Medical Inc USE OF ARGININE AS AN IMMUNE STIMULATOR
US5085883A (en) * 1991-06-27 1992-02-04 Abbott Laboratories Blend of dietary fiber for nutritional products

Also Published As

Publication number Publication date
DK0630181T3 (en) 1999-11-15
GR3030642T3 (en) 1999-10-29
DE69325091D1 (en) 1999-07-01
WO1993016595A1 (en) 1993-09-02
AU3614393A (en) 1993-09-13
EP0630181A1 (en) 1994-12-28
EP0630181B1 (en) 1999-05-26
DE69325091T2 (en) 1999-12-23
EP0630181A4 (en) 1995-07-26
US5221668A (en) 1993-06-22
CA2128078C (en) 2002-03-19
NZ249392A (en) 1996-01-26
HK1011597A1 (en) 1999-07-16
MX9300999A (en) 1993-09-01
JPH07500348A (en) 1995-01-12
JP2644086B2 (en) 1997-08-25

Similar Documents

Publication Publication Date Title
CA2128078A1 (en) Nutritional product for trauma and surgery patients
MY112705A (en) Tryglycerides
CA2158635A1 (en) Adolescent Dietary Composition
DE69806820D1 (en) CALORIOUS NUTRITIONAL COMPOSITION
CA2244608A1 (en) Nutritional product with high fat, low carbohydrate and amino acid imbalance
EP0614616A3 (en) Composition for treating patients with hepatic disease.
CA2054358A1 (en) High acid nutritional formulations
EP2258402A3 (en) Dried composition
CA2099880A1 (en) Nutritional product for persons receiving renal dialysis
CA2371696A1 (en) Composition for an infant formula having a low threonine content
CA2095889A1 (en) Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
CA2105791A1 (en) Nutrition for Persons Undergoing Radiation Therapy and/or Chemotherapy
AU7405091A (en) Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
AU1852597A (en) Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid
CA2174031A1 (en) Benzoyl peroxide compositions
CA2305598A1 (en) Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects
Chang The future prospect of traditional Korean fermented foods
AU7100094A (en) Rumen-bypass fatty acid salt and protein dietary supplement for ruminants
CA2162042A1 (en) Enteral Nutritional Product
Iwanaka et al. Ileocecal resection in neonates and infants: a follow-up study
ATE275835T1 (en) FOOD CONTAINING ZINC AND LINOLIC ACID
CA2127107A1 (en) Methods and compositions for reducing blood loss
JPH0648954A (en) High protein nutrition liquid
ZA967319B (en) Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
AU1064995A (en) Derivatives of 2,3,5,6-tetrafluorobenzoic acid and their use in combating pests

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20130208